Source / episode info

• **Episode:**553
• **Title:**DIP Ep 553: USMLE Step 2/3 Rapid Review Series 117
• **Published:**2024-12-09
• Source:Episode page

One-liner

This episode provides a rapid review of complex topics including the pathophysiology of cirrhosis and fluid waves, interpreting Hepatitis B serology and prognosis, diagnosing Minimal Change Disease (MCD) via selective proteinuria, identifying Primary Biliary Cholangitis (PBC), managing toxic megacolon, and applying IBD-related colorectal cancer screening guidelines.

High-yield summary

• Cirrhosis: Ascites formation is due to decreased albumin synthesis by the liver leading to low oncotic pressure, causing fluid transudation from mesenteric vessels.
• Minimal Change Disease (MCD): The most common cause of nephrotic syndrome in children; it is a T-cell mediated process that damages podocyte foot processes, resulting in selective proteinuria (loss of albumin). Diagnosis relies on urinalysis and electron microscopy (EM), not routine biopsy.
• Primary Biliary Cholangitis (PBC): An autoimmune disease characterized by the destruction of small intrahepatic bile ducts; key findings include elevated Alkaline Phosphatase (ALP) and Gamma-Glutamyl Transferase (GGT), positive anti-MCP antibodies, dark urine, and pale stools due to impaired bilirubin excretion.
• Hepatitis B Prognosis: In adults, acute HBV infection has a very low risk of progressing to chronic infection (>95% resolution). Conversely, vertical transmission from mother to child carries an extremely high risk of developing chronic infection.
• Toxic Megacolon Management: Suspect in severe colitis (e.g., UC); initial management requires plain film X-ray confirmation and immediate stabilization; colonoscopy or barium enema are absolutely contraindicated due to perforation risk.
• IBD/CRC Screening: If a patient has IBD with PSC, screening colonoscopy starts at the time of diagnosis and repeats every 1–2 years.

Learning objectives

• Differentiate the pathophysiology of ascites in cirrhosis based on oncotic pressure changes.
• Interpret Hepatitis B serology and apply knowledge of HBV transmission risks (adult vs. vertical).
• Recognize the classic clinical triad and laboratory findings associated with Primary Biliary Cholangitis (PBC).
• Establish the diagnostic workup for nephrotic syndrome, specifically differentiating MCD from other causes based on EM/IF findings.
• Identify critical contraindications in acute severe colitis (e.g., toxic megacolon) and outline initial management steps.